NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 173 filers reported holding NXSTAGE MEDICAL INC in Q4 2018. The put-call ratio across all filers is 5.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,574,000 | -27.2% | 89,923 | -29.1% | 0.01% | -16.7% |
Q2 2018 | $3,537,000 | -35.7% | 126,803 | -42.7% | 0.01% | -25.0% |
Q1 2018 | $5,501,000 | -10.9% | 221,269 | -13.1% | 0.01% | -11.1% |
Q4 2017 | $6,173,000 | +1559.4% | 254,727 | +1692.8% | 0.01% | +800.0% |
Q4 2016 | $372,000 | – | 14,208 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |